Bowel cancer
Intestinal cancer (carcinoma of rectum) is a common malignant tumor in the gastrointestinal tract. Its incidence rate is second only to stomach and esophageal cancer. It is the most common part of colorectal cancer (accounting for about 60%). The vast majority of patients are over 40 years old, and about 15% are under 30 years old. It is more common in men, with a male-to-female ratio of 2-3:1. Intestinal cancer should be actively prevented.
-
Site of disease:
intestinal -
Infectious :
Not contagious -
Frequent population:
Middle-aged and elderly people -
Related symptoms:
Blood in stool Loss of appetite Weight loss Feeling of incomplete defecation Abnormal bowel movement frequency -
Concurrent disease:
Related Drugs
Xiao Cancer Tablets
Manufacturer:
Henan Livu Pharmaceutical Co., Ltd.
Xiao Cancer Tablets
Manufacturer:
Hunan Shentaichun Pharmaceutical Co., Ltd.
Xiao Cancer Tablets
Manufacturer:
Nanjing Sanhome Pharmaceutical Co., Ltd.
Xiao Cancer Tablets
Manufacturer:
Shanxi Zhendong Pharmaceutical Co., Ltd.
Xiao Cancer Tablets
Manufacturer:
Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory
Xiao Cancer Tablets
Manufacturer:
Tianjin Hezhi Pharmaceutical Group Co., Ltd.
Xiao Cancer Tablets
Manufacturer:
Tianjin Hezhi Pharmaceutical Group Co., Ltd.
Xiao Cancer Tablets
Manufacturer:
Heilongjiang Tianhong Pharmaceutical Co., Ltd.
Related Ingredients
-
1,10-Phenanthroline hydrate list
5144-89-8